Michael W. Kalb - Nov 21, 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Executive Vice President & CFO
Signature
/s/ Michael W. Kalb
Stock symbol
CPRX
Transactions as of
Nov 21, 2024
Transactions value $
$0
Form type
4
Date filed
11/25/2024, 05:01 PM
Previous filing
Jan 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 +169K +57.78% $0.00 462K Nov 21, 2024 Common Stock 169K $21.12 Direct F1
transaction CPRX Restricted Stock Units Award $0 +20.7K +4.48% $0.00 483K Nov 21, 2024 Common Stock 20.7K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027.
F2 Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F3 Shares of common stock will be delivered to the Reporting Person upon vesting.